- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- 【Updated on June 30, 2025】Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
Alpha and Delta variants and vaccination effectiveness against severity in COVID-19 inpatients based on medical claims in Japan
-
- Mitsushima Shingo
- Center for Field Epidemic Intelligence, Research and Professional Development, National Institute of Infectious Diseases, Tokyo, Japan.
-
- Horiguchi Hiromasa
- Department of Clinical Data Management and Research, Clinical Research Center, National Hospital Organization Headquarters, Tokyo, Japan.
-
- Taniguchi Kiyosu
- National Hospital Organization Mie National Hospital, Mie, Japan. The Tokyo Foundation for Policy Research, Tokyo, Japan.
Search this article
Description
<p>Some mutated strains of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presumably have high infectivity and pathogenicity. Using Japanese medical claims data, we assessed the pathogenicity of Alpha and Delta variants and vaccine effectiveness by severity. Inpatient records from the Medical Information Analysis Databank for the National Hospital Organization were used. Severity was defined as the proportion of inpatients using respiratory ventilators among inpatients with oxygen administration. We regressed severity and fatality on the proportion of patients with Alpha or Delta variant and on vaccination coverage, while allowing for some lag to reflect development from infection to hospitalization. We also examined results obtained when using data for all new inpatients, instead of inpatients with oxygen administration, as the denominator for severity. Estimation results were better when using severity defined by inpatients with oxygen administration as the denominator than when using all new inpatients. Especially for severity measures for inpatients 65 years old or older with oxygen administration, we confirmed an association of vaccination with lower severity and an association of Delta variant infection with high severity. Vaccines were most effective for people 65 years old or older. The age distributions of inpatients and confirmed patients were greater than for people younger than 65 years old. Vaccination reduced severity and fatality and Alpha and Delta variants might increase severity and fatality among inpatients 65 years old or older receiving oxygen therapy. </p>
Journal
-
- GHM Open
-
GHM Open 3 (1), 28-36, 2023-08-27
National Center for Global Health and Medicine